Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksE-therapeutics Regulatory News (ETX)

Share Price Information for E-therapeutics (ETX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.40
Bid: 9.30
Ask: 9.50
Change: 0.00 (0.00%)
Spread: 0.20 (2.151%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 9.40
ETX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison issues outlook on Jersey Electricity (JEL)

14 Mar 2019 12:39

Edison Investment Research Limited Edison issues outlook on Jersey Electricity (JEL) 14-March-2019 / 12:38 GMT/BST


London, UK, 14 March 2019

Edison issues outlook on Jersey Electricity (JEL)

Jersey Electricity's (JEL) strong financial position and forecast cash flow should underpin 5% per year growth in the dividend per share. Although JEL faces wholesale cost rises, lower unit demand and a fluid regulatory situation, we believe that, given its strong position on pricing and service standards, it is well positioned to withstand these pressures. Our latest valuation analysis indicates increased upside potential from current levels.

Our updated valuation (the average of peer group multiples, using cover-adjusted yield/DCF/SOTP), indicates a valuation of c 560p (+2.5%) versus 546p last year. In particular, the increased SOTP valuation (from 552p to 592p) has been driven by a growth in regulatory assets and reduced debt. Despite a recent rise in the share price following the better than expected FY18 results released in December 2018, the shares offer 20% upside to the average of our valuation, with the prospect of growing income from the dividend.Click here to view the full report.

All reports published by Edison are available to download free of charge from its websitewww.edisoninvestmentresearch.com

About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information please contact Edison:

Graeme Moyse, +44 (0)20 3077 5700industrials@edisongroup.com

Learn more at www.edisongroup.com and connect with Edison on:LinkedIn https://www.linkedin.com/company/edison-investment-research Twitter www.twitter.com/Edison_Inv_ResYouTube www.youtube.com/edisonitv


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

787643 14-March-2019 

corporate announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
4th Apr 20184:13 pmRNSNotice of AGM
27th Mar 20187:00 amRNSFull Year Results
12th Mar 20187:00 amRNSNotification of Full Year Results Date
22nd Jan 20187:00 amRNSDirector/PDMR Shareholding
15th Jan 20187:00 amRNSE-Therapeutics enters two AI collaborations
3rd Jan 20187:00 amRNSDirector/PDMR Shareholding
18th Dec 20172:31 pmRNSHolding(s) in Company
18th Dec 20178:57 amRNSDirector/PDMR Shareholding
1st Nov 20177:00 amRNSAppointment of Director
5th Oct 201711:35 amEQSEdison issues update on e-Therapeutics (ETX)
26th Sep 20177:00 amRNSInterim Results for 6 Months Ended 31 July 2017
5th Sep 20179:41 amRNSNotice of Results
22nd Aug 20172:13 pmRNSDirector/PDMR Shareholding
27th Jul 20174:46 pmRNSEdison issues update on e-Therapeutics (ETX)
27th Jul 20173:24 pmEQSEdison Investment Research Limited: Edison issues update on e-Therapeutics (ETX)
24th Jul 20177:00 amRNSOutcome of Strategic Review and Future Plans
3rd Jul 20174:50 pmRNSDirector/PDMR Shareholding
19th Jun 201710:13 amRNSTR-1: Notification of Major Interest in Shares
5th Jun 20172:21 pmRNSTR-1: Notification of Major Interest in Shares
2nd Jun 20173:19 pmRNSTR-1: Notification of Major Interest in Shares
2nd Jun 20172:50 pmRNSTR-1: Notification of Major Interest in Shares
2nd Jun 201712:02 pmRNSTR-1: Notification of Major Interest in Shares
2nd Jun 20179:00 amRNSDirector/PDMR Shareholding
31st May 20172:01 pmRNSResults of Annual General Meeting
25th May 201711:20 amRNSNotification by Director
23rd May 20174:22 pmRNSDirector/PDMR Shareholding
8th May 20173:02 pmRNSNotice of Annual General Meeting and Annual Report
3rd May 20179:00 amRNSDirector/PDMR Shareholding
19th Apr 20177:00 amRNSFinal Results
6th Apr 20177:01 amRNSNotification of Full Year Results Date
6th Apr 20177:00 amRNSNew CEO Commences at e-Therapeutics
4th Apr 20178:30 amRNSHolding(s) in Company
4th Apr 20178:30 amRNSHolding(s) in Company
16th Feb 20177:00 amRNSDirectorate Change
12th Jan 201710:38 amRNSHolding(s) in Company
9th Jan 20177:00 amRNSAppointment of CEO
4th Jan 20177:00 amRNSDirector/PDMR Shareholding
23rd Nov 20164:21 pmRNSGrant of share options and Directors' dealings
6th Oct 201610:12 amRNSDirectors' Dealings and Issue of Equity
3rd Oct 20162:03 pmRNSFurther re: Directors' Shareholdings
21st Sep 20164:06 pmRNSIssue of Equity and Directors' shareholdings
20th Sep 20167:00 amRNSHalf year results
14th Sep 201612:08 pmRNSManagement Update
9th Sep 20169:30 amRNSNotice of Half Year Results
18th Aug 20165:07 pmRNSHolding(s) in Company - Correction
18th Aug 201611:07 amRNSHolding(s) in Company
1st Aug 20164:40 pmRNSIssue of Equity
13th Jul 201610:05 amRNSBoard changes
13th Jul 201610:00 amRNSDirectorate Change
12th Jul 20168:00 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.